215 related articles for article (PubMed ID: 26258775)
1. Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.
King TJ; Shandala T; Lee AM; Foster BK; Chen KM; Howe PR; Xian CJ
Int J Mol Sci; 2015 Aug; 16(8):18293-311. PubMed ID: 26258775
[TBL] [Abstract][Full Text] [Related]
2. Supplementation with fish oil and genistein, individually or in combination, protects bone against the adverse effects of methotrexate chemotherapy in rats.
Raghu Nadhanan R; Skinner J; Chung R; Su YW; Howe PR; Xian CJ
PLoS One; 2013; 8(8):e71592. PubMed ID: 23951199
[TBL] [Abstract][Full Text] [Related]
3. Effects of Resveratrol Supplementation on Methotrexate Chemotherapy-Induced Bone Loss.
Lee AM; Shandala T; Soo PP; Su YW; King TJ; Chen KM; Howe PR; Xian CJ
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282956
[TBL] [Abstract][Full Text] [Related]
4. Fish oil in comparison to folinic acid for protection against adverse effects of methotrexate chemotherapy on bone.
Raghu Nadhanan R; Fan CM; Su YW; Howe PR; Xian CJ
J Orthop Res; 2014 Apr; 32(4):587-96. PubMed ID: 24346859
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexate.
Fan CM; Foster BK; Hui SK; Xian CJ
PLoS One; 2012; 7(10):e46915. PubMed ID: 23071661
[TBL] [Abstract][Full Text] [Related]
7. Flavonoid genistein protects bone marrow sinusoidal blood vessels from damage by methotrexate therapy in rats.
Hassanshahi M; Su YW; Khabbazi S; Fan CM; Chen KM; Wang JF; Qian A; Howe PR; Yan DW; Zhou HD; Xian CJ
J Cell Physiol; 2019 Jul; 234(7):11276-11286. PubMed ID: 30565680
[TBL] [Abstract][Full Text] [Related]
8. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.
Xian CJ; Cool JC; Scherer MA; Fan C; Foster BK
J Cell Physiol; 2008 Mar; 214(3):777-85. PubMed ID: 17786974
[TBL] [Abstract][Full Text] [Related]
9. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
[TBL] [Abstract][Full Text] [Related]
10. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.
Georgiou KR; Scherer MA; Fan CM; Cool JC; King TJ; Foster BK; Xian CJ
J Cell Physiol; 2012 Mar; 227(3):909-18. PubMed ID: 21503894
[TBL] [Abstract][Full Text] [Related]
12. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation.
King TJ; Georgiou KR; Cool JC; Scherer MA; Ang ES; Foster BK; Xu J; Xian CJ
Am J Pathol; 2012 Jul; 181(1):121-9. PubMed ID: 22642908
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects.
Xian CJ; Cool JC; Scherer MA; Macsai CE; Fan C; Covino M; Foster BK
Bone; 2007 Nov; 41(5):842-50. PubMed ID: 17884747
[TBL] [Abstract][Full Text] [Related]
15. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling.
Georgiou KR; Nadhanan RR; Fan CM; Xian CJ
J Cell Physiol; 2015 Mar; 230(3):648-56. PubMed ID: 25187349
[TBL] [Abstract][Full Text] [Related]
17. Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.
Su YW; Chen KM; Hassanshahi M; Tang Q; Howe PR; Xian CJ
Ann N Y Acad Sci; 2017 Sep; 1403(1):109-117. PubMed ID: 28662275
[TBL] [Abstract][Full Text] [Related]
18. Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats.
Kolios L; Sehmisch S; Daub F; Rack T; Tezval M; Stuermer KM; Stuermer EK
Planta Med; 2009 Apr; 75(5):459-65. PubMed ID: 19241330
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
[TBL] [Abstract][Full Text] [Related]
20. Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss.
Raghu Nadhanan R; Abimosleh SM; Su YW; Scherer MA; Howarth GS; Xian CJ
Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1440-9. PubMed ID: 22436700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
